Researcher.Life Logo

Journal of Neuromuscular Diseases : Impact Factor & More

eISSN: 2214-3602pISSN: 2214-3599

Key Metrics

CiteScore
5.5
H-Index
34
Impact Factor
< 5
SJR
Q1Neurology
SNIP
1.3
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Neuromuscular Diseases

Journal of Neuromuscular Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher IOS PRESS
Language English
Frequency Annual
General Details
LanguageEnglish
FrequencyAnnual
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Neuromuscular Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Neuromuscular Diseases

Role of next generation sequencing in neonatal diagnosis and screening.
  • 28 Nov 2025
  • Journal of neuromuscular diseases
Limitations in activities of daily living in individuals with spinal muscular atrophy: A scoping review and multidisciplinary recommendations for clinical practice.
  • 26 Nov 2025
  • Journal of neuromuscular diseases
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.
  • 24 Nov 2025
  • Journal of neuromuscular diseases
Unveiling MYH2-related myopathy: Histological-genetic insights from a case series and systematic review.
  • 18 Nov 2025
  • Journal of neuromuscular diseases
Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.
  • 18 Nov 2025
  • Journal of neuromuscular diseases
MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review.
  • 12 Nov 2025
  • Journal of neuromuscular diseases
Role of next generation sequencing in neonatal diagnosis and screening.
  • 28 Nov 2025
  • Journal of neuromuscular diseases
Limitations in activities of daily living in individuals with spinal muscular atrophy: A scoping review and multidisciplinary recommendations for clinical practice.
  • 26 Nov 2025
  • Journal of neuromuscular diseases
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.
  • 24 Nov 2025
  • Journal of neuromuscular diseases
Unveiling MYH2-related myopathy: Histological-genetic insights from a case series and systematic review.
  • 18 Nov 2025
  • Journal of neuromuscular diseases
Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.
  • 18 Nov 2025
  • Journal of neuromuscular diseases
MT-ATP6 variant as a cause of adult-onset hereditary spastic paraparesis: A case report and literature review.
  • 12 Nov 2025
  • Journal of neuromuscular diseases

FAQs on Journal of Neuromuscular Diseases